Agios Pharmaceuticals | AGIO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 384.69B 19.14B 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Arrowhead Research USD 8.78B 236M 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
AstraZeneca USD 201.06B 88.93B 2026-07
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Exelixis USD 10.89B 857M 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Novartis USD 264.25B 23.66B 2026-07
Novartis USD 319.89B 31.63B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 235.82B 34.18B 2026-07
Sarepta Therapeutics USD 2.28B 30M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03